Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
Conditions
- Cardiomyopathy
- Heart Failure
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
Interventions
- OTHER: Best Practice
- OTHER: Laboratory Biomarker Analysis
- DRUG: Mesenchymal Stem Cell Transplantation
- DRUG: Mesenchymal Stem Cell Transplantation
Sponsor
M.D. Anderson Cancer Center
Collaborators